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Background:  The estimated prevalence of coronary artery disease (CAD) in patients with ESLD varies from 2 to 30%. CAD is associated 
with worse outcomes in liver transplant recipients. The value of SPECT MPI in screening for ischemia and assessing pre-operative risk is 
poorly defined in patients with ESLD.
methods:  Retrospective data from our institutional stress database were reviewed. Patients undergoing preoperative MPI from 10/2004 to 
06/2012 were included. Mortality data was compiled using the United States Social Security Death Index.
results:  Overall, 5441 consecutive patients underwent preoperative MPI, of which 274 had ESLD. Inducible ischemia was found in 951 
out of 5167 (18.4%) patients without ESLD , and 33 out of 241 (12%) patients with ESLD (p=0.0077). For ESLD patients with ischemia vs. 
no ischemia, mortality was numerically higher at 30 days (9.1% vs. 3.3%, p=0.13) and 1 year (30.3% vs. 21.2%, p=0.26) but did not reach 
statistical significance. For non-ESLD patients, there was a significant difference in mortality at 1 year (11.4% vs. 8.4%, p=0.0057) for those 
with ischemia vs. no ischemia, but no significant mortality difference at 30 days (1.7% vs.1.2%, p=0.1978).
conclusion:  Patients with ESLD in need of pre-operative risk stratification are less likely to have ischemia on MPI compared to those 
without ESLD, but clearly remain at a higher risk of death. SPECT MPI was unable to identify those patients with ESLD at a higher mortality 
risk in the short or medium term.
 
